Background and Purpose-The harsh host brain microenvironment caused by production of reactive oxygen species after ischemic reperfusion injury offers a significant challenge to survival of transplanted neural stem cells (NSCs) after ischemic stroke. Copper/zinc-superoxide dismutase (SOD1) is a specific antioxidant enzyme that counteracts superoxide anions. We have investigated whether genetic manipulation to overexpress SOD1 enhances survival of grafted stem cells and accelerates amelioration of ischemic stroke. Methods-NSCs genetically modified to overexpress or downexpress SOD1 were administered intracerebrally 2 days after transient middle cerebral artery occlusion. Histological and behavioral tests were examined from Days 0 to 28 after stroke. Results-Overexpression of SOD1 suppressed production of superoxide anions after ischemic reperfusion injury and reduced NSC death after transplantation. In contrast, downexpression of SOD1 promoted superoxide generation and increased oxidative stress-mediated NSC death. Transplantation of SOD1-overexpressing NSCs enhanced angiogenesis in the ischemic border zone through upregulation of vascular endothelial growth factor. Moreover, grafted SOD1-overexpressing NSCs reduced infarct size and improved behavioral performance compared with NSCs that were not genetically modified. Conclusions-Our findings reveal a strong involvement of SOD1 expression in NSC survival after ischemic reperfusion injury. We propose that conferring antioxidant properties on NSCs by genetic manipulation of SOD1 is a potential approach for enhancing the effectiveness of cell transplantation therapy in ischemic stroke. (Stroke. 2012;43:2423-2429.)
NSCs were isolated from the subventricular zones of postnatal Day 1 green fluorescent protein (GFP) Tg mice, SOD1/GFP double Tg mice, and SOD1 KO/GFP Tg mice as described. 11 
Induction of Oxygen-Glucose Deprivation
We used oxygen-glucose deprivation (OGD) and reoxygenation (RO), an in vitro model that best mimics in vivo cerebral ischemia and reperfusion. NSCs were subjected to OGD and RO by replacing the medium with a buffered salt solution without glucose. The plates were placed in an anaerobic chamber at 37°C. After 8 hours, the medium was replaced with culture medium with glucose and the plates were returned to a 5% CO 2 /95% air incubator for various RO periods.
In Situ Detection of Superoxide Anion Production
Hydroethidine was used for the detection of early production of superoxide anions as previously described. 12 Production of superoxide anions was shown by oxidized hydroethidine as diffuse signals and small particles in the cytosol.
Focal Cerebral Ischemia
Adult male C57BL/6 mice (26 -30 g) were subjected to transient focal cerebral ischemia by 45 minutes of intraluminal middle cerebral artery blockade with a suture as described previously. 13 
Cell Transplantation
Three 1.0-L deposits of NSCs (1ϫ10 5 cells/L) were transplanted into the peri-infarct cortex 2 days after stroke.
Statistical Analysis
Behavioral data were assessed using repeated-measures analysis of variance. We used Scheffé post hoc analysis of a Rotorod test and analyzed modified neurological severity scores using the SteelDwass test. For other experimental data, comparisons among multiple groups were performed with one-way analysis of variance followed by Scheffé post hoc analysis. Data are expressed as median for the modified neurological severity scores and meanϮSD for the other experiments. Significance was accepted with PϽ0.05.
Full Methods
The full methods are detailed in the online-only Data Supplement.
Results

Characterization of NSCs
We isolated the NSCs from fetal GFP Tg mice ( WT NSCs), SOD1/GFP double Tg mice ( Tg NSCs), or SOD1 KO/GFP Tg mice ( KO NSCs). These NSCs, grown as adherent cultures, were self-renewing and multipotent ( Figure IA 
SOD1 Expression in NSCs
We next investigated the expression of SOD1 in the WT NSCs, Tg NSCs, and KO NSCs. Western blot analysis revealed that SOD1 expression was significantly higher in the Tg NSCs (2.97-, 2.8-fold) and lower in the KO NSCs (0.32-, 0.35-fold) than in the WT NSCs under both normal conditions and after OGD and RO, respectively ( Figure 1A ). In contrast, manganese-superoxide dismutase expression was similar among the 3 groups. Immunocytochemistry demonstrated that total SOD1 signals (mouseϩhuman) in the cytosol increased in the Tg NSCs associated with human SOD1 expression, whereas total SOD1 signals remarkably decreased in the KO NSCs ( Figure 1B ). 
Involvement of SOD1 Expression in NSC Death In Vitro
We next asked if the levels of SOD1 expression were associated with NSC death after ischemic reperfusion injury. After 8 hours of OGD and 15 minutes of RO, WT NSCs showed a significant increase in hydroethidine signals in the cytosol, which represents production of superoxide anions ( Figure 2A ). This signal increase was significantly reduced in the Tg NSCs, whereas it was enhanced in the KO NSCs. Terminal deoxynucleotidyl transferase-mediated uridine 5Ј-triphosphate-biotin nick end labeling (TUNEL) staining exhibited increased TUNEL positivity in the WT NSCs after 8 hours of OGD and 24 hours of RO. TUNEL positivity was decreased in the Tg NSCs and was exacerbated in the KO NSCs ( Figure 2B ). Moreover, a lactate dehydrogenase assay showed reduced death (by 22%) of the Tg NSCs as well as enhanced death (by 22%) of the KO NSCs after 8 hours of OGD and 24 hours of RO compared with the WT NSCs ( Figure  2C ). These findings were also supported by a WST-1 assay ( Figure 2D ). Furthermore, SOD1 overexpression reduced and SOD1 downexpression increased lactate dehydrogenase release from the NSCs subjected to the oxidative stimuli H 2 O 2 and diethylenetriamine/nitric oxide ( Figure IIA -B in the online-only Data Supplement).
SOD1 Overexpression Reduced Grafted Cell Death In Vivo
We transplanted WT NSCs, Tg NSCs, or KO NSCs into the peri-infarct cortex 2 days after stroke ( Figure III in the online-only Data Supplement). When the WT NSCs were transplanted into the ischemic brains, hydroethidine signals drastically increased 1 hour after transplantation compared with those in the intact brains ( Figures 3A and 3C ). SOD1 overexpression significantly diminished this increase, whereas hydroethidine signals were significantly elevated in the KO NSC group compared with the WT NSC group. We next counted the number of TUNEL-positive cells that were also GFP-positive 2 days after transplantation. When the WT NSCs were transplanted into the peri-infarct cortex, the number of TUNEL-positive grafted cells increased significantly com- pared with those in the intact brains. However, this increased TUNEL positivity was significantly reduced by 43% in the Tg NSC group (Figures 3B and 3D ).
Increased Survival of Grafted NSCs With SOD1 Overexpression In Vivo
Twenty-eight days after stroke, staining with GFP revealed an extensive migration of grafted cells toward the ischemic lesion border in the 
Transplantation of
Tg
NSCs Enhanced Angiogenesis In Vivo
Secretion of vascular endothelial growth factor by transplanted NSCs is involved in functional recovery after ischemic stroke. 14 Therefore, vascular endothelial growth factor levels in the cortex were measured by a sandwich enzymelinked immunosorbent assay 4 days after stroke. These levels significantly increased in the Tg NSC group compared with the nontransplanted control and WT NSC groups ( Figure 5A ). To analyze the effects of the NSCs on angiogenesis, we examined the density of lectin-perfused vessels in the peri-infarct cortex 14 days after stroke, which revealed a significantly higher blood vessel density in the Tg NSC group than in the nontransplanted control and WT NSC groups (Figures 5B and 5C). However, this enhanced angiogenesis was not observed in the WT NSC or KO NSC groups.
Mice Transplanted With
Tg
NSCs Exhibited Amelioration of Ischemic Stroke
To investigate whether transplantation of NSCs could promote amelioration of ischemic stroke, infarct size was measured by hematoxylin and eosin staining 28 days after stroke.
Transplantation of
Tg NSCs significantly reduced the cortical infarct size by 19.8% and 13.1% compared with the nontransplanted control and WT NSC groups ( Figure 6A ). No changes were observed in striatal infarct size among the 4 groups (data not shown). In addition, a significantly larger number of neurons was observed in the peri-infarct cortex in the Tg NSC group than the nontransplanted control and WT NSC groups ( Figure IV in the online-only Data Supplement). We next analyzed behavioral performance using the Rotorod test and modified neurological severity scores. The mice that received Tg NSCs showed significant functional improvement from Day 7 compared with the nontransplanted control group and from Day 21 compared with the WT NSC group according to the Rotorod test ( Figure 6B ). Although a statistical significance was not observed, the Tg NSC group showed behavioral improvement as indicated by the modified neurological severity scores ( Figure 6C ). Significant behavioral improvement was not observed in the WT 
Discussion
We have demonstrated in this study that SOD1 played a pivotal role in protecting NSCs from ischemic reperfusion injury. The major findings are: (1) SOD1 overexpression increased survival of NSCs after ischemic reperfusion injury by enhancing the antioxidant capacity; (2) downexpression of SOD1 accelerated oxidative stress-mediated NSC death; and (3) transplantation of Tg NSCs attenuated infarct size and promoted functional recovery. These findings provide evidence that conferring antioxidant properties on grafted stem cells by genetically manipulating SOD1 expression enhances the effectiveness of stem cell therapy in ischemic stroke.
Although little information exists about the effects of ROS on NSCs, recent reports have shown that NSCs use ROS to regulate proliferation, self-renewal, and neurogenesis under physiological conditions. 15 Although it is controversial whether NSCs generally have lower or higher endogenous ROS levels than their differentiated progeny, [15] [16] [17] these cells seem to possess an enhanced antioxidant capacity against oxidative stress compared with more differentiated cells because of the high expression of antioxidant enzymes, including uncoupling protein 2 and glutathione peroxidase. 16 This activity may be a protective mechanism in stem cell populations with active oxidantmediated signaling to prevent an excess of or toxic levels of ROS from being generated. Regardless of these reports, we have found in this study that a large number of NSCs suffered oxidative stress-mediated death after ischemic reperfusion injury. In line with our data, excessive oxidative stress generated under pathophysiological conditions is reported to be toxic for survival of NSCs. 18 -21 These findings lead us to surmise that genetic modification of NSCs to overexpress antioxidant enzymes might be beneficial for promoting survival of these grafted cells.
Because the proliferation and differentiation capacity of the NSCs are highly dependent on endogenous ROS levels under physiological conditions, manipulating the expression of antioxidant enzymes may unexpectedly change their pro- files. 15, 22, 23 For example, conditional deletion of phosphatase and tensin homolog on chromosome 10 in nestin-expressing NSCs in the developing brain and in glial fibrillary acidic protein-expressing stem cells in the subventricular zone of the adult brain promoted and sustained NSC self-renewal and neurogenesis, contributing to brain overgrowth. 24 -26 In contrast, Tg NSCs as well as KO NSCs demonstrated similar proliferation and differentiation capacities in our study compared with WT NSCs. In addition, neither the SOD1 Tg nor the KO mice had any difference from the WT mice in phenotypes, including brain size. 27 This discrepancy might be because the basal expression of antioxidant or pro-oxidant enzymes in Tg NSCs and KO NSCs is altered in association with SOD1 expression and compensates for the regulation of ROS levels. Further study is needed to clarify this important issue. In the present study, we were able to identify the cell type in less than half of the grafted cells in vivo. However, because tumor formation was not observed even 3 months after transplantation indicates that the grafted cells did not transform into tumorigenic cells.
In this study, we focused on the cytoprotective effects of SOD1 in NSCs. First, SOD1 overexpression reduced ROS levels and increased NSC survival after ischemic reperfusion injury. This is consistent with our previous studies showing that SOD1 overexpression exhibited neuroprotection in rodent brains after transient focal cerebral ischemia and transient global cerebral ischemia. 8 -10,28,29 Second, SOD1 downexpression contributed to enhanced oxidative stress and increased NSC death. This agrees with our previous reports showing that a reduction in SOD1 activity led to larger infarct size and brain swelling after ischemic stroke. 30, 31 These findings indicate a strong relationship between SOD1 expression and NSC survival under pathophysiological conditions. Thus, we propose that genetic manipulation of SOD1 is a potential molecular target for stem cell therapy in ischemic stroke.
Despite many preclinical studies showing that cell transplantation can ameliorate ischemic stroke, the mechanisms mediating recovery are not well known. The majority of exogenous stem cells under investigation exert so-called "nursing functions" to the injured brain such as cytoprotection or stimulation of endogenous repair mechanisms. 1, 32 Considering the reduced cortical infarct size and increased blood vessel density in the ischemic brain, neuroprotection and angiogenesis might be among the main therapeutic actions of transplanted NSCs in the present study. Reduced grafted cell death with SOD1 overexpression might contribute to the enhanced accumulation of neuroprotective trophic factors, including proangiogenic vascular endothelial growth factor, that are secreted from NSCs. 14 In this study, we performed subacute delivery of NSCs, which has more clinical relevance than acute delivery. However, subacute delivery might limit the neuroprotective action of the NSCs. We conclude that this is why the behavioral improvement observed in the present study was relatively small and occurred at a later time point.
NSC groups (nϭ12). Behavioral performance using the Rotorod test (B) and mNSS (C). Transplantation of the Tg NSCs showed the greatest functional improvement in the Rotarod test (nϭ12
Conclusions
We have shown the strong involvement of SOD1 expression in NSC survival after ischemic reperfusion injury. Our findings indicate that conferring antioxidant properties on NSCs by genetic manipulation of SOD1 is a potential approach for enhancing the effectiveness of cell transplantation therapy in ischemic stroke.
Materials and Methods
Animals
All animals were treated in accordance with Stanford University guidelines and the animal protocols were approved by Stanford University's Administrative Panel on Laboratory Animal Care. Homozygous GFP Tg mice [C57BL/6-Tg(UBC-GFP)30Scha/J; The Jackson Laboratory, Bar Harbor, ME] were bred with heterozygous SOD1 Tg mice (C57BL/6 background, backcrossed with C57BL/6 for more than 10 generations) or heterozygous SOD1 KO mice (C57BL/6 background, backcrossed with C57BL/6 for more than 10 generations) to generate heterozygous GFP Tg mice, heterozygous SOD1/GFP double Tg mice, and heterozygous SOD1 KO/GFP Tg mice. 1 These animals were used for isolation of NSCs. We also used WT C57BL/6 mice (The Jackson Laboratory) for middle cerebral artery occlusion models. Animals were randomized into groups. All methods and assessments described below were carried out by individuals blinded to the groups.
Isolation and Culture of Fetal NSCs
NSCs were isolated from the heterozygous GFP Tg mice, heterozygous SOD1/GFP double Tg mice, and heterozygous SOD1 KO/GFP Tg mice as described, 2 with some modification. In brief, 
Assessment of Cell Death and Cell Viability In Vitro
Cell death was examined by a standard measurement of LDH release using a LDH-cytotoxicity assay kit (K311-400; BioVision, Mountain View, CA). The amount of released LDH was assessed in an aliquot of the cell medium, using the manufacturer's instructions. Cell viability was analyzed with a cell proliferation reagent using a WST-1 assay kit (05015944001; Roche Diagnostics, Indianapolis, IN). For in situ labeling of DNA fragmentation, the NSCs were prepared as described in the immunofluorescent staining section. An in situ cell death detection kit, TMR red (12156792910; Roche Diagnostics), was used according to the manufacturer's instructions. Slides were covered with VECTASHIELD mounting medium with DAPI and observed with fluorescence microscopy.
Focal Cerebral Ischemia
Adult male C57BL/6 mice (26 to 30 g) were anesthetized with 2.0% isoflurane in 30% oxygen and 70% nitrous oxide using a face mask. The rectal temperature was controlled at 37°C with a homeothermic blanket. Physiological parameters were monitored throughout the surgeries. After a midline skin incision, the right external carotid artery was exposed, and its branches were electrocoagulated. A 6-0 monofilament nylon suture coated with silicon rubber (6023PK5Re; Doccol Corp., Redlands, CA) was introduced into the right internal carotid artery through the external carotid artery stump. After 45 minutes of middle cerebral artery occlusion, blood flow was restored by withdrawal of the suture. The animals were maintained in an air-conditioned room at 20°C with ad libitum access to food and water before and after surgery. Every mouse included in the study showed circling toward the paretic side directly after the surgery, indicating that infarct was successfully produced. A total of four mice died in the first 24 hours after induction of stroke and were excluded from the study (one mouse in the non-transplanted control group, one mouse in the WT NSC group, one mouse in the Tg NSC group, and one mouse in the KO NSC group.).
Intracerebral NSC Transplantation
The mice were anesthetized 2 days after the onset of stroke and the NSCs were transplanted were counted using unbiased computational stereology (fractionator method, using STEREOINVESTIGATOR software [MicroBrightfield, Inc., Williston, VT]), as described.
3
Quantification of Survival of the Transplanted NSCs
The transplanted GFP-positive cells were counted using unbiased computational stereology as described above. The sections were stained with GFP and DAPI. All the GFP-positive cells were counted on six serial coronal sections per brain (1 mm apart).
Assessment of NSC Differentiation Profiles
The proportion of GFP-positive cells, also stained with lineage-specific phenotype markers (β-tubulin and GFAP), was determined by confocal microscopy. Split panel and z axis analyses were used for all counting. One hundred or more GFP-positive cells were scored for both markers per animal.
Detection of VEGF Fresh brain tissue was removed 2 days after transplantation. The rectangular cuboid tissue block of the cortex, 1 mm on either side of the NSC-transplanted regions, was dissected (width 2 mm × length 5 mm) and used as a sample. Protein was extracted as described in the Western blot analysis section. Commercial VEGF ELISA kits (MMV00; R&D Systems, Minneapolis, MN)
were used to quantify the concentration of VEGF-A in each of the samples.
BVD Analysis
BVD was assessed 14 days after stroke as described previously, 4 with some modifications.
Briefly 
Measurement of Infarct Size
The brain sections were stained with H&E. We estimated the cortical/striatal infarct size as a percentage of the ipsilateral cortex/striatum using the following: [(area of contralateral cortex/striatum) -(area of remaining ipsilateral cortex/striatum)/(area of contralateral cortex/striatum) × 100]. The area of both sides of the cortex and striatum was measured on six serial coronal sections per brain (1 mm apart), and the area of the infarct was quantified over these six levels using Adobe Photoshop (Adobe Systems, San Jose, CA).
Quantification of Neuronal Survival
The brain sections were stained with NeuN and DAPI as described above. 
Behavioral Analysis
A rotarod test and mNSS were examined by two individuals, blinded to the mouse-treatment status, on the day of the stroke surgery (baseline), and at 2, 7, 14, 21, and 28 days after the onset of stroke. The mNSS are the result of a battery of motor and coordination tests assessing the severity of neurological deficits on a graded scale ranging from 0 to 14, where 0 represents normal function and 14 represents maximal deficits as described. 5 For the rotarod test, after 3 days of training prior to the stroke surgery, the mice were 
